Fact CheckerSign in

NCT07444515Recruiting

Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients.

Source: ClinicalTrials.gov · Last updated 16 Sept 2026

Brief summary (registry, in English)

We propose the following hypotheses: * The use of herbal medicine is common among patients with chronic kidney disease in Réunion island. * This use could influence the progression of kidney disease in these patients. To assess the primary inclusion criterion, patients will be easily identified by nephrologists through existing follow-up. The questionnaires will be administered after this early identification by the investigators at each center. The primary evaluation criterion is straightforward: it aims to establish an overview of the use of herbal medicine in our patient population. This information is currently unavailable and remains crucial for measuring the extent of the issue. Our secondary criteria will involve more in-depth analysis of this use and an attempt to correlate the use of certain herbs with the rate of progression of kidney disease at one year. We targeted patients with moderate to end-stage chronic kidney disease (KDIGO classification 3 to 5), which are the stages typically included in kidney disease studies. Furthermore, these patients are the most likely to experience a greater annual progression of their kidney disease, and the effect of herbs on this progression could be investigated. Transplant patients were not included because they are more aware of the risks of not using herbal medicine due to their use of immunosuppressants.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
400 (estimated)
First submitted
26 Feb 2026
Start date
Jul 2026
Primary completion date
Jul 2027
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
NCT number
NCT07444515

What you commit to

  • Study type: Interventional
  • Planned participants: 400
  • From Jul 2026 to the primary completion date, Jul 2027
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Kidney transplant recipient

Other

  • Individual:
  • Adult under guardianship or legal protection
  • Pregnant or breastfeeding women, or women planning a pregnancy during the enrollment period

Who the study is looking for

  • Individual:
  • Adult
  • Resident of Réunion Island and planning to remain on the island for the year following enrollment
  • Chronic Kidney Disease Stage 3, 4, or 5, not on dialysis
  • Under the care of a nephrologist
  • Able to complete a questionnaire
  • Registered with social security

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Groupe Hospitalier Est Réunion
Coordinator of this site? Confirm its status
Saint-BenoîtFranceRecruiting
CHU Reunion site 1
Coordinator of this site? Confirm its status
Saint-DenisFranceRecruiting
AURAR
Coordinator of this site? Confirm its status
Saint-PaulFranceRecruiting
CHU Reunion site 2
Coordinator of this site? Confirm its status
Saint-PierreFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.